FATE - Fate Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

FATE is currently covered by 3 analysts with an average price target of $6.25. This is a potential upside of $5.23 (512.75%) from yesterday's end of day stock price of $1.02.

Fate Therapeutics's activity chart (see below) currently has 257 price targets and 232 ratings on display. The stock rating distribution of FATE is 60% BUY and 40% HOLD.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 52.63% of the time, taking 125.63 days on average.

Highest price target for FATE is $8, Lowest price target is $3, average price target is $6.25.

Most recent stock forecast was given by YANAN ZHU from WELLS FARGO on 06-Nov-2026.

Currently out of the existing stock ratings of FATE, 3 are a BUY (60%), 2 are a HOLD (40%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 27-Mar-2023

$3

$1.72 (134.38%)

$3.5

12 days ago
(06-Nov-2026)

2/5 (40%)

$1.16 (63.04%)

49

Buy Since 14-Aug-2024

$8

$6.72 (525.00%)

$6

3 months 4 days ago
(14-Aug-2026)

19/26 (73.08%)

$5.43 (211.28%)

264

Buy Since 04-May-2026

$7

$5.72 (446.88%)

$7

5 months 10 days ago
(08-Jun-2026)

0/6 (0%)

$5.09 (266.49%)

Hold Since 27-Feb-2024

$7

$5

1 years 22 days ago
(27-Oct-2025)

12/17 (70.59%)

$5.45 (351.61%)

133

Buy Since 12-Mar-2020

$7

$10

1 years 2 months 15 days ago
(03-Sep-2025)

1/5 (20%)

$6 (600.00%)

36

Show more analysts

Please expand the browser size to see the chart

What is FATE (Fate Therapeutics) average time for price targets to be met?

On average it took 126 days for the stock forecasts to be reached, with an average price target met ratio of 52.63%.

Which analyst most recently updated their price target on FATE (Fate Therapeutics)?

Yanan Zhu

Which analyst has the most public recommendations on FATE (Fate Therapeutics)?

Yanan Zhu works at WELLS FARGO and has 15 price targets and 8 ratings on FATE

Which analyst is the currently most bullish on FATE (Fate Therapeutics)?

Edward White with the highest potential upside of $120.72

Which analyst is the currently most reserved on FATE (Fate Therapeutics)?

Peter Lawson with the lowest potential downside of -$0.1
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?